The rising diagnosis rates of gluten intolerance and celiac
disease globally are a significant factor driving the market.
Awareness of these conditions has increased, leading to more people
seeking treatment and dietary solutions.
WILMINGTON, Del., July 22, 2024 /PRNewswire/ -- The
gluten intolerance treatment market was projected to
attain US$ 593.5 million in
2023. It is likely to garner a 13.9% CAGR from 2024 to 2034,
and by 2034, the market is expected to attain US$ 2.5 billion.
The gluten-free food and beverage sector is expanding rapidly,
driven by consumer demand for gluten-free alternatives. This growth
supports the gluten intolerance treatment market by providing more
dietary options for affected individuals. There is a continuous
innovation in the formulation of gluten-free products, aiming to
improve taste, texture, and nutritional value. This trend is making
gluten-free diets more appealing and sustainable for consumers.
Personalized treatment plans and precision medicine are becoming
more common, tailored to individual genetic profiles and specific
needs, enhancing treatment efficacy for gluten intolerance. The
rise of e-commerce and online retail platforms has made gluten-free
products more accessible to a broader audience, contributing to
market growth.
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86215
Investment in the development of new pharmaceutical treatments,
such as enzyme supplements that can break down gluten or drugs that
can modify the immune response, presents a considerable
opportunity. Increasing educational campaigns about gluten
intolerance, its symptoms, and management strategies can lead to
higher diagnosis rates and greater market demand.
Leveraging biotechnology to create innovative products, such as
genetically modified grains that are safe for gluten-intolerant
individuals, could revolutionize the market. The increasing
availability of gluten-free options in restaurants and fast-food
chains is making it easier for individuals with gluten intolerance
to adhere to their dietary needs, thereby increasing market
demand.
Gluten Intolerance Treatment Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 593.5 Mn
|
Forecast (Value) in
2034
|
US$ 2.5 Bn
|
Growth Rate
(CAGR)
|
13.9 %
|
No. of
Pages
|
132
Pages
|
Segments
covered
|
By Drug Type, By
Indication, By Distribution Channel, By Region
|
Key Findings of Market Report
- There is ongoing research into non-dietary therapies such as
vaccines, probiotics, and microbiome therapies, which could
offer alternative treatment options and expand the market.
- Consumers are increasingly demanding transparency regarding
ingredients and quality in gluten-free products, pushing
manufacturers to improve their product offerings.
- Advancements in food technology, such as better gluten
substitutes and improved manufacturing processes, are enhancing the
quality and variety of gluten-free products.
- Utilizing AI to predict and diagnose gluten intolerance more
accurately can lead to earlier intervention and better management,
boosting market growth.
Market Trends for Gluten Intolerance Treatment
- By drug type, the antihistamines segment is expected to boost
the growth of the gluten intolerance treatment market.
- Antihistamines are used to manage allergic reactions, including
those triggered by gluten intolerance.
- They can help alleviate symptoms such as itching, rash, and
swelling, which are common in individuals with gluten sensitivity
or allergic reactions.
- With improved awareness and diagnostic capabilities for gluten
intolerance, more individuals are seeking symptomatic relief,
driving demand for antihistamines as part of their treatment
regimen.
- In terms of indication, the celiac disease segment is
anticipated to accelerate the market growth.
- There is a growing awareness and improved diagnostic techniques
for celiac disease, leading to more accurate and earlier diagnosis
of the condition.
Unlock Growth Potential in Your Industry! Download PDF
Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86215
Global Market for Gluten Intolerance Treatment: Regional
Outlook
North America
- North America has a relatively
high prevalence of celiac disease and gluten sensitivity.
- The increasing diagnosis rates in the region drive the demand
for gluten intolerance treatments.
- There is a growing awareness among healthcare providers and the
general population about gluten intolerance, leading to improved
diagnosis rates.
- Increased awareness encourages more individuals to seek medical
advice and treatment options.
Asia Pacific
- Global dietary trends, including the adoption of gluten-free
diets, are increasingly influencing Asia
Pacific countries.
- This shift is fueled by health consciousness, rising disposable
incomes, and a growing middle-class population.
- Many countries in Asia Pacific
are investing in healthcare infrastructure development,
improving access to healthcare services, diagnostic facilities, and
specialty clinics that cater to gastrointestinal disorders,
including gluten intolerance.
Gluten Intolerance Treatment Market: Key Players
The competitive landscape of the gluten intolerance treatment
market is characterized by a mix of pharmaceutical companies,
biotechnology firms, food manufacturers, and specialty product
providers.
The market is competitive due to the rising prevalence of gluten
intolerance and celiac disease, increasing consumer awareness, and
demand for effective treatments and gluten-free products. The
following companies are well known participants in the gluten
intolerance treatment market:
- Precigen ActoBio
- Calypso Biotech SA
- Alvine Pharmaceuticals Inc.
- ImmusanT
- Artielle ImmunoTherapeutics
- FunZyme Biotechnologies
- Innovative BioPharma
- AMYRA Biotech AG
- Vactech Composites Pvt. Ltd.
- Alba Therapeutics Corporation
- PvP Biologics Inc.
Key Development
- In 2023, Amgen filed a patent outlining a method for treating
celiac disease, also referred to as non-celiac gluten sensitivity,
using an antigen-binding fragment or an anti-IL-15 antibody.
Gluten Intolerance Treatment Market
Segmentation
Drug Type
- Antihistamines
- Epinephrine
Indication
- Celiac Disease
- Dermatitis Herpetiformis
- Depression
- Gluten Ataxia
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86215<ype=S
More Trending Reports by Transparency Market
Research:
- Vendor Neutral Archive (VNA) Market - The
global vendor neutral archive (VNA) market is projected to advance
at a CAGR of 12.6% from 2024 to 2034
- Interleukins Market - The global
interleukins market is projected to expand at a CAGR of
15.9% during the forecast period from 2024 to 2034
- Medical Tubing Market - Ongoing advancements in
material science offer lucrative opportunities to market players.
Manufacturers are focusing on introducing innovative materials in
order to increase market revenue.
- Tumor Ablation Market is estimated to grow at a
CAGR of 6.9% from 2023 to 2031 and reach US$ 2.3 Bn by the end of 2031
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington, Delaware, United States, provides custom research and
consulting services. Our exclusive blend of quantitative
forecasting and trends analysis provides forward-looking insights
for thousands of decision makers. Our experienced team of Analysts,
Researchers, and Consultants use proprietary data sources and
various tools & techniques to gather and analyses
information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington,
Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn| Twitter|
Blog | YouTube
Logo -
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/gluten-intolerance-treatment-market-to-reach-us-2-5-billion-by-2034--growth-at-cagr-13-9--report-by-transparency-market-research-inc-302202930.html